Paclitaxel+Carboplatin Clinical Trials

3 actively recruiting trials across 1 location

▲ +1 trial since May 2026

Also known as: Paclitaxel group, Wee1 inhibitor+ PARAPLATIN+Taxol

Pipeline

Phase 3: 1Phase 1/2: 1Phase 2/3: 1

Top Sponsors

Wigen Biomedicine Technology (Shanghai) Co., Ltd.1
Shengjing Hospital1
Eikon Therapeutics1

Indications

Cancer3
Non Small Cell Lung Cancer (Squamous or Non Squamous)1
Stage 4 NSCLC1
Advanced Solid Tumor1
Lung Cancer1

Other2 trials

A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors

Phase 1/2

Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT

Phase 3

Mineola, New York1 trial

A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

NYU Langone Hospital Long Island

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.